Description
RRS® HA Long Lasting is a sterile, resorbable dermal implant designed for skin revitalisation, long-lasting hydration, and improvement of early signs of skin ageing. Developed by Skin Tech Pharma Group, the product combines BDDE cross-linked hyaluronic acid with a protective amino acid buffer intended to support hydration, antioxidant protection, and dermal regeneration.
RRS® HA Long Lasting is positioned within the category of hybrid skin boosters and biorevitalising injectables. It is commonly used to improve skin elasticity, superficial to moderate wrinkles, dermal atrophy, and photoaged skin. The formulation contains 21 mg/3 ml cross-linked hyaluronic acid together with 15 amino acids that help stabilise the HA while supporting tissue quality and hydration.
The product is frequently selected for patients presenting with dull, dehydrated, lax, or prematurely aged skin, particularly in facial areas such as the cheeks, jawline, nasolabial folds, and marionette lines. Results may remain visible for approximately 9–12 months depending on patient-specific factors and treatment protocol.
What RRS® HA Long Lasting Is Similar To
RRS® HA Long Lasting is often compared with injectable skin boosters and biorevitalisers such as Profhilo and Jalupro Super Hydro due to its focus on hydration, skin quality improvement, and collagen-supportive activity.
Like Profhilo®, RRS® HA Long Lasting uses hyaluronic acid to improve hydration and skin elasticity. However, RRS® HA Long Lasting incorporates an amino acid protective buffer and cross-linked HA structure intended to prolong hydration effects and support antioxidant activity.
Compared with Jalupro Super Hydro, RRS® HA Long Lasting also combines HA with amino acids, but it is generally positioned more toward long-lasting hydration and dermal support rather than intensive collagen biostimulation alone. The product is additionally described by some distributors as a hybrid between a skin booster and a soft dermal filler due to its cross-linked HA composition.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
Manufacturer and distributor information indicates use for:
- Face
- Jawline
- Cheeks
- Chin
- Nasolabial folds
- Marionette lines
- Décolletage
- Hands
- Areas affected by photoaging and dermal atrophy
Primary indications include:
- Skin hydration
- BioRevitalisation
- Improvement of skin elasticity
- Reduction of superficial and moderate wrinkles
- Support for photoaged skin
- Improvement of tired or dull skin appearance
Usage / Administration (IFU-Only Section)
According to publicly available manufacturer and distributor guidance:
- Recommended injection depth: deep dermis
- Suggested needle size: 30G needle
- Proposed maintenance schedule: 1–3 booster sessions may be performed depending on clinical outcome
- Injection volume per point: not provided by manufacturer
- Number of sessions: not provided by manufacturer
- The product should only be administered by qualified medical professionals under appropriate aseptic conditions.
Some practitioners apply a “7-point technique”; however, this is not clearly established within the official manufacturer IFU guidance and may vary according to practitioner preference.
Ingredient List
Active ingredients include:
- BDDE cross-linked hyaluronic acid – 21 mg / 3 ml
- Protective amino acid buffer
- 15 amino acids
- Hydrating and antioxidant stabilising components
Lidocaine concentration: not provided by manufacturer
Presentation & Longevity
- Packaging: 1 × 3 ml prefilled syringe
- Product type: sterile resorbable dermal implant
- HA origin: non-animal biotechnological origin
- Estimated duration: approximately 9–12 months depending on patient characteristics, lifestyle, skin condition, and injection protocol.
Shelf life: not provided by manufacturer
Safety Notes / Contraindications
Contraindications and precautions may include:
- Hypersensitivity to hyaluronic acid or any formulation component
- Active skin infection or inflammation at the treatment site
- Pregnancy and breastfeeding
- Treatment should only be performed by qualified medical professionals
- Use in damaged or compromised skin should be clinically assessed before treatment
As with all injectable aesthetic procedures, temporary redness, swelling, bruising, tenderness, or irritation may occur following administration.
Regulatory Status
RRS® HA Long Lasting is described as a Class III sterile medical device manufactured in conformity with European Directive 93/42/EEC.
CE marking status is referenced within public manufacturer documentation. Users should verify the latest regulatory classification directly from the product packaging or official IFU before purchase or administration.
FAQ
Is RRS® HA Long Lasting a filler?
RRS® HA Long Lasting is commonly described as a hybrid product positioned between a skin booster, biorevitaliser, and soft dermal implant. While it contains cross-linked hyaluronic acid similar to dermal fillers, its primary objective is skin hydration, revitalisation, and improvement of skin quality rather than major volumisation. Some distributors refer to it as a “hybrid filler” because of its prolonged hydration effect and structural support properties.
What does RRS® HA Long Lasting contain?
The formulation contains 21 mg of BDDE cross-linked hyaluronic acid in a 3 ml syringe combined with a protective amino acid buffer containing 15 amino acids. The amino acids are intended to support hydration, antioxidant activity, and tissue regeneration while helping stabilise the hyaluronic acid.
How long do RRS® HA Long Lasting results last?
Publicly available product information suggests that results may remain visible for approximately 9–12 months. Longevity can vary according to patient age, skin condition, lifestyle, metabolic activity, and treatment technique. Some practitioners may recommend maintenance or booster sessions to prolong clinical outcomes.
What treatment areas can be treated with RRS® HA Long Lasting?
The product is primarily indicated for facial rejuvenation and skin quality improvement. Commonly treated areas include the cheeks, jawline, chin, nasolabial folds, marionette lines, hands, and décolletage. It is frequently selected for dehydrated, photoaged, or lax skin showing early ageing changes.
What injection depth is recommended for RRS® HA Long Lasting?
Available manufacturer-related guidance indicates administration into the deep dermis using a fine needle, commonly a 30G needle. Publicly accessible documentation does not consistently specify volume per injection point or a mandatory treatment protocol, therefore practitioners should consult the official IFU before use.
